| Value | ₹0.36 Cr |
|---|
NSE filing, NSE: PIDILITIND. Summary written from the filing by ALFA Finder's alert engine.
Pidilite Industries Ltd: key numbers
- Share price
- ₹1,389.60
- Market cap
- ₹1,41,536 Cr
- Revenue (annual)
- ₹14,601 Cr
- Net profit (annual)
- ₹2,449 Cr
- P/E (TTM)
- 52.7×Sector 34.1×
- Promoter holding
- 69.18%-0.06% QoQ
- FII holding
- 12.42%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pidilite Industries Ltd
All →Pidilite Industries Investor Presentation: Key Takeaways
Standalone Q2 FY27 net sales Rs 3,982 Cr (+21.7%) and PAT Rs 647 Cr (+10.4%), with EBITDA margin compressed to 20.4% by input-cost inflation. Consolidated PAT grew 7.1%.
Pidilite Industries Results Update
Pidilite reported Q2 FY27 standalone net sales of Rs 3,982 crore, up 21.7%, with PAT up 10.4%. EBITDA margin was 20.4% after input cost headwinds.
Pidilite Industries Q2 FY27 Results: Net Profit ₹626.5 Cr, Up 7.2% YoY
Pidilite Industries Ltd reported revenue from operations of ₹4,298 Cr (+20.9% YoY) and net profit of ₹626.5 Cr (+7.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹626.5 Cr · +7.2% YoY
Pidilite Industries Management Change
Pidilite appointed Manish Airee as CBO-CC Retail and Huzefa Kanchwala as CBO-Roff effective 27 October 2026. Both are Senior Management Personnel elevated internally.
Pidilite Industries Employee Stock Options
Pidilite granted 1,44,270 stock options under ESOP-2016 at an exercise price of ₹1 per option to eligible employees. Vesting is staggered over October 2027 to January 2029.
Pidilite Industries Other Announcement
Pidilite Industries Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.